硫化调节编程细胞死亡的作用:对心血管疾病的影响
Qing-Bo Lu1, Xue-Xue Zhu2, Guo Chen2
1Department of Endocrinology, Affiliated Hospital of Jiangnan University, Jiangnan University, Wuxi, China.
Antioxidants & redox signaling
|October 25, 2025
概括
硫化 (H2S) 在心血管疾病 (CVD) 中起着关键作用. 本综述探讨了H2S如何调节各种心血管疾病中编程细胞死亡 (PCD) 途径,突出了未来研究的领域.
科学领域:
- 生物化学和分子生物学
- 心血管研究研究心血管研究
- 细胞死亡机制 细胞死亡机制
背景情况:
- 硫化 (H2S) 是一个关键的信号分子,与心血管疾病 (CVD) 有关.
- 多种编程细胞死亡 (PCD) 模式,包括NETosis,apoptosis和ferroptosis,越来越多地被认为是它们在心血管疾病发病过程中的作用.
- 在心血管疾病的背景下,H2S影响这些PCD通路的确切机制仍然不完全理解.
研究的目的:
- 在心血管疾病的背景下,审查和总结目前对H2S对各种PCD通路的监管影响的理解.
- 阐明H2S在糖尿病心肌病,高血压和动脉样硬化等疾病中调节PCD的潜在机制.
- 确定关键的知识差距,并提出未来的研究方向H2S介导的PCD在心血管健康和疾病.
主要方法:
- 文献综述和对H2S,PCD和CVD现有研究的综合.
- 对调查H2S对特定PCD模式 (亡,亡,烧亡,铁亡,亡,NETosis) 的影响的研究分析.
- 检查H2S在不同心血管细胞类型和疾病模型中的作用.
主要成果:
- 在与心血管疾病相关的各种PCD途径中,H2S表现出复杂的调节作用.
- 有证据表明,H2S可以影响PCD在包括糖尿病心肌病,心脏缩,高血压,心力衰竭,动脉样硬化和缺血/再输液损伤在内的疾病.
- 在不同的心血管细胞类型和疾病背景下,H2S对PCD的影响存在显著差异.
结论:
- 了解H2S对PCD途径的调制对于破译其在心血管疾病中的病理生理学作用至关重要.
- 需要进一步的研究来阐明H2S对PCD的特定分子机制和细胞类型依赖的影响.
- 未来的研究应该采用先进的技术,在实时和各种疾病条件下绘制H2S调节的PCD事件.
相关概念视频
Peroxisomes
19.9K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
19.9K
Overview of Cell Death
9.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.4K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Apoptosis
14.0K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.0K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K


